Inhaled dry-powder formoterol and salmeterol in asthmatic patients: Onset of action, duration of effect and potency

European Respiratory Journal

Volumn 10, Issue 11, 1997, Pages 2484-2489

  Palmqvist, M ^a   Persson, G ^b   Lazer, L ^c   Rosenborg, J ^d   Larsson, P ^d   Lotvall J ^a,e  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d Clinical Research and Development   (Sweden)

^e SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

2 agonist; Asthma; Formeterol; Onset; Potency; Salmeterol

Indexed keywords

BRONCHODILATING AGENT; FORMOTEROL; SALBUTAMOL; SALMETEROL;

ADULT; ARTICLE; ASTHMA; BRONCHODILATATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATION; INHALATIONAL DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; ADRENERGIC BETA-AGONISTS; ADULT; AGED; ALBUTEROL; ASTHMA; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ETHANOLAMINES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; POWDERS; TIME FACTORS;

EID: 0031471788     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10112489     Document Type: Article

References (21)

1. Ullman A, Svedmyr N. Salmeterol, a new long acting inhaled beta-2-agonist: a comparison with salbutamol. Thorax 1988; 43: 674-678.
2. Löfdahl CG, Svedmyr N. Formoterol fumarate, a new beta-2-adrenoceptor agonist. Allergy 1989; 44: 246-271.
3. Lötvall J, Svedmyr N. Salmeterol: An inhaled beta-2-agonist with prolonged duration of action. Lung 1993; 171: 249.
4. Rabe KF, Jörres R, Nowak D, Behr N, Magnussen H. Comparison of the effects of Salmeterol and formoterol on airway tone and responsiveness over 24 hours in bronchial asthma. Am Rev Respir Dis 1993; 147: 1436-1441.
5. Fitzpatrick MF, Mackay T, Driver H, Douglas NJ. Salmeterol in nocturnal asthma: a double-blind placebo controlled trial of a long acting inhaled beta-2-agonist. Br Med J 1990; 301: 1365-1368.
6. Arvidsson P, Larsson S, Löfdahl CG, Melander B, Wåhlander L, Svedmyr N. Inhaled formoterol during one year in asthma. A comparison with salbutamol. Eur Respir J 1991; 4: 1168-1173.
7. Kesten S, Chapman KR, Broder I, et al. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Am Rev Respir Dis 1991; 144: 622-625.
8. Greening AP, Ind PW, Northfield M, Shaw G. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Lancet 1994; 344: 219-224.
9. Lötvall J, Lunde H, Hedner J, Svedmyr N. Onset of bronchodilation and tremor inducing effect of salmeterol and salbutamol (albuterol) up to two hours after inhalation. Am Rev Respir Dis 1994; 149: A206 (suppl).
10. Wegener T, Hedenström H, Melander B. Rapid onset of action of inhaled formoterol in asthmatic patients. Chest 1992; 102: 535-538.
11. Linsen VMJ, Bindels HJC, van Nord JA. A direct comparison of the time of onset of action between inhaled formoterol and salmeterol. Eur Respir J 1993; 6 (Suppl. 17): 591.
12. Ball DI, Brittain RT, Coleman RA, et al. Salmeterol, a novel, long-acting beta-2-adrenoceptor agonist: characterization of pharmacological activity in vitro and in vivo. Br J Pharmacol 191; 104: 665-671.
13. Ullman A, Bergendal A, Lindén A, Waldeck B, Skoogh B-E, Löfdahl C-G. Onset of action and duration of effect of formoterol and salmeterol compared with salbutamol in isolated guinea pig trachea with or without epithelium. Allergy 1992; 47: 384-387.
14. Jeppsson AB, Nilsson E, Waldeck B. Formoterol and salmeterol are both long acting compared to terbutaline in the isolated perfused guinea pig lung. Eur J Pharmacol 1994; 257: 137-143.
15. Wallin A, Sandström T, Rosenhall L, Melander B. Time course and duration of bronchodilation with formoterol dry powder in patients with stable asthma. Thorax 1993; 48: 611-614.
16. Ringdal N, Derom E, Pauwels R. Onset and duration of action of single doses of formoterol inhaled via Turbuhaler in mild to moderate asthma. Eur Respir J 1995; 8: Suppl. 19, 68s.
17. van Noord J, Smeets JJ, Raaijmakers JAM, Bommer AM, Maesen FPV. Salmeterol versus formoterol in patients with moderately severe asthma: onset and duration of action. Eur Respir J 1996; 9: 1684-1688.
18. Lindén A, Bergendal A, Ullman A, Skoogh B-E, Löfdahl C-G. Salmeterol, formoterol and salbutamol in the isolated guinea pig trachea: differences in maximum relaxant effect and potency but not in functional antagonism. Thorax 1993; 48: 547-553.
19. Naline E, Zhang Y, Qian Y, et al. Relaxant effects and durations of action of formoterol and salmeterol on the isolated human bronchus. Eur Respir J 1994; 7: 914-920.
20. Löfdahl C-G, Andersson L, Carlsson LG, et al. Lower nominal dose required of inhaled salbutamol via Turbuhaler compared with pressurized metered-dose inhaler, for the same bronchodilating effect. Am Resp Crit Care Med 1994; 149: A219.
21. Hörnblad V, Jemsby P, Rosenborg J, Werner S, Svedmyr N. Salbutamol doses inhaled via Turbuhaler gives a better bronchodilating effect than given via pressurised metered dose inhalers. Eur Respir J 1994; 7: Suppl. 18, 49S.